Peptide 6 - The Breakthrough Human Growth Hormone (HGH) Releaser
Another exciting advancement in age management medicine! This peptide is now approved for general use as a substitute for Human Growth Hormone (HGH). HGH is known as the most effective medication to slow the aging process, but has had legal issues in the United States because of abuse. The strict limitations for using HGH are now avoided by using this new peptide (GHRP-6). HGH is a 191-amino acid peptide produced by the pituitary gland and regulated by two chemicals - Growth Hormone Releasing Hormone (GHRH) and Somatostatin (SST). Nutrition and exercise also influences its release. Once HGH is released, it carries out numerous functions in the human body. Under the influence of HGH, cells increase in both size and number, stimulating growth in the body's cells. It also has the ability to enhance the movement of amino acids through cellular membranes and increases the rate at which these cells convert amino acids into useful proteins. Muscle building and repair, as well as growing new neurons (brain and nerve cells), depend on the presence of adequate HGH. Cognitive decline with aging is due to the absence of adequate HGH. Fat loss with an increase in lean muscle mass has been found to occur even with small doses of HGH.
When does the body actually secrete HGH? The largest quantities are secreted at night while asleep. This is another important reason to get adequate sleep. GHRH (Growth Hormone Releasing Hormone) is responsible for the release of growth hormone while you sleep.
A most interesting part of all is that HGH has the ability to re-grow cartilage! Its use for degenerative joint disease has been mostly ignored and underutilized until now. Rehabilitating old injuries and fractures could be vastly improved with the use of HGH.
In our later years, the body produces less HGH, and its effects are profound. HGH is a great compound for muscle gains and fat-loss with its loss causing the weight gain and loss of muscle mass about which we all complain.
One word of caution]
Here's the BIG news! An improvement in HGH increase and regulation is now available. GHRP-6, a 28-amino-acid peptide that signals the human body to begin secreting HGH is now available for use in our age management programs. Use of GHRP-6 to release HGH has many very attractive health benefits such as]
o Decrease body fat
o Promotes collagen growth
o Stimulates growth of new bone
o Reduces excess weight gain
o Reduces Insulin resistance
o Reduces risk of Obesity (Adiposity)
o Stimulates the Immune system, particularly in older patients
Many bodybuilders and athletes have recently started using GHRP-6 in an effort to build more muscle and burn more fat. It is a critical part of the cycling they routinely do, particularly when preparing for a show or competition. GHRP-6 should be part of your age-management protocol, and prescribed by someone very familiar with all its properties and benefits.
I suppose these GHS will be targeted as they are prohibited by the WADA...we will see*
ABSTRACT]Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry.
Rapid Commun Mass Spectrom, July 1, 2010
Anti-Doping Center, Mitsubishi Chemical Medience Corporation, Tokyo, Japan.
GHRP-2 (pralmorelin, D-Ala-D-(beta-naphthyl)-Ala-Ala-Trp-D-Phe-Lys-NH(2)), which belongs to a class of growth hormone secretagogue (GHS), is intravenously used to diagnose growth hormone (GH) deficiency. Because it may be misused in expectation of a growth-promoting effect by athletes, the illicit use of GHS by athletes has been prohibited by the World Anti-Doping Agency (WADA). Therefore, the mass spectrometric identification of urinary GHRP-2 and its metabolite D-Ala-D-(beta-naphthyl)-Ala-Ala-OH (AA-3) was studied using liquid chromatography/electrospray ionization tandem mass spectrometry for doping control purposes. The method consists of solid-phase extraction using stable-isotope-labeled GHRP-2 as an internal standard and subsequent ultra-performance liquid chromatography/tandem mass spectrometry, and the two target peptides were determined at urinary concentrations of 0.5-10 ng/mL. The recoveries ranged from 84 to 101%, and the assay precisions were calculated as 1.6-3.8% (intra-day) and 1.9-4.3% (inter-day). Intravenous administration of GHRP-2 in ten male volunteers was studied to demonstrate the applicability of the method. In all ten cases, unchanged GHRP-2 and its specific metabolite AA-3 were detected in urine.
Reply With Quote